| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |